News & Stories for Oregonians
Available in Spanish Summer vacation is almost over, and back-to-school time is upon us. No matter how you and your learners like to prepare for the start of the school year—shopping for new folders, catching up on summer reading or soaking up the remaining sunny days—be sure to add getting caught up COVID-19 vaccinations to […]
Available in Spanish The COVID-19 vaccines made by Pfizer and Moderna use messenger RNA (mRNA) technology, which allows scientists to test, deliver and modify the vaccines quickly. The ability to adapt quickly is on full display this summer. On June 28, as Omicron BA.5 became the predominant COVID-19 variant in the United States, the U.S. […]
Available in Spanish Updated 10/20: Novavax is authorized as a booster dose in some situations. Yesterday, July 13, the U.S. Food and Drug Administration (FDA) authorized for emergency use the COVID-19 vaccine Novavax for adults age 18 and older. The Novavax vaccine is different from the other three vaccines available in the United States. It […]
Available in Spanish A recent report from the Centers for Disease Control and Prevention (CDC) shows people who survive COVID-19 are significantly more likely to have certain health complications than those who have no evidence of ever having COVID-19. These types of lingering health complications linked to a COVID-19 infection are commonly referred to as […]
To read this story in Spanish, click here. Update, June 17: The FDA released a statement this morning authorizing the use of both Pfizer and Moderna’s vaccines down to age 6 months. Moderna’s vaccine is also now FDA-authorized for children ages 6 months through 17 years. The vaccine was already authorized for people age 18 […]
To read this story in Spanish, click here. As early as next week, parents and caregivers may be able to get their youngest children vaccinated against COVID-19. The U.S. Food and Drug Administration’s advisory committee is meeting tomorrow, June 15, to review applications for emergency use for Moderna and Pfizer’s pediatric COVID-19 vaccines. Moderna’s application […]
To read this story in Spanish, click here. The Western States Scientific Safety Review Workgroup has authorized a single booster dose of the pediatric Pfizer COVID-19 vaccine for children ages 5 through 11. The group’s decision Thursday evening follows recommendations from the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) […]
Los Centros para el Control y la Prevención de Enfermedades (CDC) recomiendan que algunas personas, especialmente los hombres de 12 a 39 años esperen hasta ocho semanas entre la primera y la segunda dosis de una serie de vacunas de Moderna o Pfizer. Si bien el riesgo ya es bajo, estudios recientes sugieren que una […]
Last week, Oregon Health Authority updated its weekly breakthrough report to include breakthrough cases in people who have received booster doses of a COVID-19 vaccine. This new set of data shows how well booster doses can protect against COVID-19 infection and severe disease. In the report, a graph divides case numbers into three categories, “unvaccinated,” […]
Las infecciones por COVID-19 se están disparando en Oregón. Estamos viendo un fuerte aumento en los casos de avance entre los vacunados, y las personas no vacunadas previamente infectadas se infectan por segunda vez. Este aumento se debe en parte a que la inmunidad disminuye y en parte a que las mutaciones en Ómicron le permiten evadir la inmunidad previamente adquirida.